LivaNova (LIVN) Cash from Operations Growth (3y) (2019 - 2026)
LivaNova (LIVN) Cash from Operations Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.91 Bn | 193.31 Bn | 7.27 Bn | 27.41% |
| 2 | Stryker | 127.59 Bn | 124.11 Bn | 4.50 Bn | 22.38% |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 1.51% |
| 4 | Boston Scientific | 73.24 Bn | 72.70 Bn | 3.85 Bn | 30.85% |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 168.71% |
| 6 | Dexcom | 34.38 Bn | 32.44 Bn | 830.00 Mn | 12.26% |
| 7 | GE HealthCare Technologies | 33.96 Bn | 31.85 Bn | 2.18 Bn | 65.19% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 43.79% |
| 9 | Steris | 23.08 Bn | 22.60 Bn | 684.20 Mn | 9.30% |
| 10 | LivaNova | 4.29 Bn | 3.77 Bn | 273.67 Mn | 78.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 78.76% |
| Mar 31, 2026 | -9.83% |
| Dec 31, 2025 | 63.93% |
| Sep 30, 2025 | 33.64% |
| Jun 30, 2025 | 101.18% |
| Mar 31, 2025 | -2.46% |
| Dec 31, 2024 | 32.97% |
| Sep 30, 2024 | 28.64% |
| Jun 30, 2024 | 19.15% |
| Mar 31, 2024 | -19.98% |
| Dec 31, 2023 | 13.42% |
| Sep 30, 2023 | 27.96% |
| Jun 30, 2023 | 1.93% |
| Mar 31, 2023 | 29.98% |
| Dec 31, 2022 | 86.87% |
| Sep 30, 2022 | 35.09% |
| Jun 30, 2022 | 19.17% |
| Mar 31, 2022 | 135.62% |
| Dec 31, 2021 | 17.03% |
| Sep 30, 2021 | -22.30% |